Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 6:18 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2593–2616 of 6,928 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Stroke
Interventions: Operant conditioning of motor evoked potentials; Other
Lead sponsor: University of Houston; Other
Eligibility: 40 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Primary Cervical Dystonia
Interventions: transcranial electrical stimulation; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Apraxia Speech
Interventions: Transcranial Magnetic Stimulation (TMS); Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Functional Movement Disorder
Interventions: MagStim, Sham Comparator; Device · Other
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Childhood Apraxia of Speech
Interventions: ASSIST; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 4 Years to 9 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: filgrastim, cyclophosphamide, paclitaxel, thiotepa, peripheral blood stem cell transplantation, radiation therapy; Biological · Drug · Procedure + 1 more
Lead sponsor: Northwestern University; Other
Eligibility: Up to 60 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2008
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Tinnitus
Interventions: Lenire Device; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Stroke
Interventions: Dexedrine, Active tDCS, Speech Therapy, Placebo, Sham tDCS; Drug · Device · Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: TMD, Temporomandibular Disorders (TMDs)
Interventions: nVNS Treatment; Device
Lead sponsor: Arpana Church; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Healthy, Fragile X Syndrome
Interventions: Follicle Aspiration; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Metabolic Diseases
Interventions: Oral Glucose Tolerance Test, Kisspeptin, Placebo; Diagnostic Test · Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Parkinson Disease
Interventions: Rhythmic Auditory Stimulation (RAS); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy, Anxiety
Interventions: Active continuous theta burst stimulation, Sham continuous theta burst stimulation; Device
Lead sponsor: University of Pittsburgh; Other
Eligibility: 30 Years to 50 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Breast Cancer
Interventions: filgrastim, carboplatin, cyclophosphamide, doxorubicin hydrochloride, paclitaxel, thiotepa, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: City of Hope Medical Center; Other
Eligibility: Up to 60 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2013
U.S. locations: 2
States / cities: Phoenix, Arizona • Duarte, California

Conditions: Ischemic Stroke, Cognitive Impairment
Interventions: tDCS, sham tDCS, Cognitive Therapy; Device · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 90 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy
Interventions: Standard HD-tDCS intervention, Multifocal network targeted HD-tDCS intervention, Functional Magnetic Resonance Imaging (fMRI); Device
Lead sponsor: University of Michigan; Other
Eligibility: 65 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Melanoma
Interventions: MCS110, Dabrafenib, Trametinib; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Post-Concussion Syndrome, COVID Long-Haul, COVID-19
Interventions: percutaneous electrical nerve-field stimulation, PENFS, percutaneous electrical nerve-field stimulation, PENFS (sham device), percutaneous electrical nerve-field stimulation, PENFS (COVID active device); Device
Lead sponsor: Children's Hospital of Orange County; Other
Eligibility: 11 Years to 18 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Orange, California

Conditions: Stage II Childhood Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
Interventions: brentuximab vedotin, etoposide, prednisone, doxorubicin, cyclophosphamide, Dacarbazine(R), filgrastim, quality of life assessment, radiation therapy; Drug · Other · Radiation
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 18 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2028
U.S. locations: 6
States / cities: Palo Alto, California • Peoria, Illinois • Scarborough, Maine + 2 more

Conditions: Substance Use Disorder (SUD)
Interventions: Transcutaneous Auricular Vagus Nerve Stimulation; Device
Lead sponsor: Daisy Thompson-Lake; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Alcohol Use Disorder
Interventions: High-density transcranial alternating current stimulation, Sham stimulation, Motivational interviewing; Device · Behavioral
Lead sponsor: The Mind Research Network; Other
Eligibility: 21 Years to 60 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Depressive Disorder, Major, Suicide
Interventions: Accelerated Theta Burst Stimulation, Sham Stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Stanford, California

Conditions: Apnea of Prematurity
Interventions: SVS mattress; Device
Lead sponsor: Tufts Medical Center; Other
Eligibility: 0 Days to 3 Months
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Birmingham, Alabama • Boston, Massachusetts

Conditions: Obsessive-Compulsive Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Sham; Device
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Operant Conditioning for Rehabilitation After Stroke

Transcranial Electrical Stimulation for Cervical Dystonia

Transcranial Magnetic Stimulation (TMS) for Primary Progressive Apraxia of Speech (PPAOS)

Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders

ASSIST: Treatment for Childhood Apraxia of Speech

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation

Dextroamphetamine and tDCS to Improve the Fluency

Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.

Aromatase Activity and Ovarian Growth Factors in African-American Versus Caucasian Women

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test

Effects of RAS on Gait in PD Patients With DBS

Neuromodulation of Brain and Emotional Responses to Psychological Stress

Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke

Multifocal HD-tDCS and Motor Function

MCS110 With BRAF/MEK Inhibition in Patients With Melanoma

Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)

Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma

Auricular Vagal Neuromodulation for Depression and Anxiety in Substance Use Disorder

A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol

Rapid Acting TMS for Suicide Ideation in Depression

"Prapela® SVS Incubator Pad for Apnea of Prematurity

Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)